Order results by:
| Issue | Title | |
| Vol 17, No 3 (2025) | Curcumin as add-on therapy in patients with multiple sclerosis showing a suboptimal response to first-line disease-modifying therapies: clinical outcomes and in vitro data | Abstract similar documents |
| A. D. Kukushkina, V. S. Rogovskii, E. V. Ponevezhskaia, E. V. Lysogorskaia, A. N. Boyko | ||
| "... to the development of disease-modifying therapies (DMTs), which are classified into first- and second-line drugs ..." | ||
| Vol 16 (2024): (Suppl. 2) | Curcumin as an add-on therapy for multiple sclerosis in patients receiving interferon-beta therapy | Abstract similar documents |
| A. D. Kukushkina, V. S. Rogovskii, E. V. Ponevezhskaya, E. V. Lysogorskaia, A. N. Boyko | ||
| "... of first-line MS disease-modifying therapy (DMTs) is a very current issue. Such a boost is needed to reduce ..." | ||
| Vol 15 (2023): (Suppl. 1) | Prospects for the use of curcumin as an additional treatment for multiple sclerosis | Abstract similar documents |
| V. S. Rogovskii, A. D. Kukushkina, A. N. Boyko | ||
| "... effects (especially when second-line disease-modifying therapies (DMT) are used). In this context ..." | ||
| Vol 14, No 1S (2022): Спецвыпуск: рассеянный склероз | Ways to improve adherence to long-term injection therapy in multiple sclerosis using the example of pegylated interferon-β1a (sampeginterferon β-1a) | Abstract similar documents |
| A. N. Boyko | ||
| "... Patient adherence to therapy with multiple sclerosis disease-modifying treatments (MS DMTs ..." | ||
| Vol 13, No 1S (2021): Спецвыпуск: рассеянный склероз | Attitude to reproduced disease modifying therapies in patients with relapsing-remitting multiple sclerosis: results of a medical and sociological study | Abstract similar documents |
| Ya. V. Vlasov, M. V. Churakov, E. V. Sineok, A. N. Boyko | ||
| "... of Russian patients to the reproduced disease modifying therapies (DMTs) and features influencing an attitude ..." | ||
| Vol 16 (2024): (Suppl. 2) | Sampeginterferon beta-1a in clinical practice | Abstract similar documents |
| I. A. Sokolova, O. S. Kornakova, E. V. Sokolova | ||
| "... In multiple sclerosis (MS), the development and introduction of disease-modifying treatments (DMTs ..." | ||
| Vol 15 (2023): (Suppl. 1) | Prolonged observation after the use of cladribine in multiple sclerosis: efficacy and safety | Abstract similar documents |
| A. D. Kukushkina, A. N. Boyko | ||
| "... of a greater number of highly effective drugs that alter the course of MS (disease-modyfyung therapies, DMTs ..." | ||
| Vol 16 (2024): (Suppl. 2) | Experience with the use of cladribine tablets in real-life clinical practice: independent analysis of data from 12 Russian clinical centres | Abstract similar documents |
| A. N. Boyko, V. M. Alifirova, D. V. Pashkovskaya, E. I. Kuchina, S. A. Sivertseva, E. L. Turova, Z. A. Goncharova, O. Yu. Rudenko, Yu. Yu. Pogrebnova, F. A. Khabirov, T. I. Khaibullin, N. N. Babicheva, N. L. Khoroshilova, O. V. Dzundza, O. A. Soldatova, A. N. Belova, G. Е. Sheiko, A. Е. Makarova, N. G. Glavinskaya | ||
| "... 12 (5.1%) of these patients had not previously received disease-modifying therapies (DMTs), i ..." | ||
| Vol 16 (2024): (Suppl. 2) | Analysis of the experience with once-weekly intramuscular administration of interferon beta-1a in the Russian population of patients with relapsing-remitting multiple sclerosis | Abstract similar documents |
| F. A. Khabirov, E. V. Granatov, A. Ya. Dykhanov, T. I. Khaibullin | ||
| "... in the treatment of the Russian population of patients with RRMS with other MS disease-modifying treatments (DMTs ..." | ||
| Vol 12, No 5 (2020) | Recommendations for switching patients with highly active multiple sclerosis from other disease modifying drugs for multiple sclerosis to cladribine tablets | Abstract similar documents |
| N. A. Totolyan, V. M. Alifirova, K. Z. Bakhtiyarova, A. N. Boyko, Ya. V. Vlasov, Z. A. Goncharova, M. N. Zakharova, D. S. Kasatkin, S. V. Kotov, A. I. Nilov, S. A. Sivertseva, A. A. Sokolova, N. N. Spirin, F. A. Khabirov, D. Paradnika | ||
| "... , which has been registered in Russia in March 2020. The paper discusses indications for changing therapy ..." | ||
| Vol 12, No 3 (2020) | Recommendations for the use of cladribine tablets for the pathogenetic treatment of patients with highly active multiple sclerosis | Abstract similar documents |
| K. Z. Bakhtiyarova, A. N. Boyko, Ya. V. Vlasov, Z. A. Goncharova, M. V. Davydovskaya, M. N. Zakharova, N. A. Malkova, A. I. Nilov, S. A. Sivertseva, N. N. Spirin, N. A. Totolyan, F. A. Khabirov, M. V. Shumilina | ||
| "... activity signs that are detected by magnetic resonance imaging (MRI) regardless of previous therapy with MS ..." | ||
| Vol 8, No 4 (2016) | GLATIRAMER ACETATE IS A FIRST-LINE DUAL-ACTION DRUG FOR THE TREATMENT OF RELAPSING-REMITTING MULTIPLE SCLEROSIS | Abstract similar documents |
| T. E. Shmidt | ||
| "... . The drug has proven to be effective and safe if administered long-term. Therapy with glatiramer acetate has ..." | ||
| Vol 13, No 1S (2021): Спецвыпуск: рассеянный склероз | Clinical presentation and course of multiple sclerosis in patients with herpesvirus infection | Abstract similar documents |
| M. S. Gris, N. S. Baranova, N. N. Spirin, D. S. Kasatkin, D. V. Kiselev, E. G. Shipova | ||
| "... -remitting MS; 14% – secondary progressive MS. 98 (80%) patients received disease modifying therapies (DMTs ..." | ||
| Vol 11, No 4 (2019) | Current requirements for studies of drugs for the pathogenetic treatment of multiple sclerosis | Abstract similar documents |
| A. N. Boyko, N. N. Spirin, Ya. V. Vlasov, M. N. Zakharova | ||
| "... such studies using the well-known drugs as a comparison group. The efficiency and safety of new therapy should ..." | ||
| Vol 16 (2024): (Suppl. 2) | Multifactorial model of predictors of the development of depressive disorders in multiple sclerosis: a prospective longitudinal study | Abstract PDF (Eng) similar documents |
| K. V. Gubskaia, Yа. V. Malygin, A. Yu. Aleksandrova | ||
| "... and the use of MS disease-modifying treatments (DMTs). The diagnosis of depression was made according ..." | ||
| Vol 14, No 1S (2022): Спецвыпуск: рассеянный склероз | Results of a study of the quality of life in patients with highly active multiple sclerosis in Russia | Abstract similar documents |
| A. N. Boiko, K. Z. Bakhtiyarova, M. A. Sherman, Z. A. Goncharova, I. V. Smagina, T. I. Khaibullin, N. N. Babicheva, N. N. Spirina, I. A. Yampolskaya-Gosteva, I. A. Sokolova, I. V. Greshnova, V. E. Nikitenkova, I. G. Lukashevich, A. V. Inzhinova, N. A. Malkova, D. S. Korobko, O. V. Boyko, I. S. Lozovskaya | ||
| "... exacerbations without taking specific pathogenetic therapy or one exacerbation during taking MS disease ..." | ||
| Vol 1, No 1 (2009) | MEDICAL INFORMATION IN THE STRUCTURE OF COGNITIVE THERAPY FOR PANIC DISORDER | Abstract similar documents |
| A. M. Burno | ||
| "... The paper describes the procedure of cognitive therapy for panic disorder, which is based ..." | ||
| Vol 1, No 1 (2009) | ANTITHROMBIC THERAPY IN THE PRIMARY PREVENTION OF STROKE | Abstract similar documents |
| I. S. Yavelov | ||
| Vol 16, No 3 (2024) | Diffusion tensor tomography with tractography in assessment of the pyramidal system in patients with highly active multiple sclerosis | Abstract similar documents |
| A. N. Peshkin, G. T. Toniya, E. A. Stepanova, V. Yu. Lizhdvoi, S. V. Kotov | ||
| "... ) during treatment switching from first-line MS therapy to second-line therapy due to suboptimal response ..." | ||
| Vol 8, No 4 (2016) | USE OF DIMETHYL FUMARATE IN THE TREATMENT OF MULTIPLE SCLEROSIS: CLINICAL AND ECONOMIC ANALYSIS | Abstract similar documents |
| V. R. Mkrtchyan, L. V. Brylev, I. A. Shpak, A. M. Sergeev | ||
| "... опережает препараты, изменяющие течение РС (ПИТРС), второй линии натализумаб и финголимод. По клинико ..." | ||
| Vol 9, No 1 (2017) | Clinical and epidemiological features of patients with multiple sclerosis in the Kursk Region | Abstract similar documents |
| V. B. Laskov, E. A. Logacheva, E. E. Tretyakova, M. A. Gridnev | ||
| "... назначенных препаратов, изменяющих течение РС (ПИТРС). Пациенты и методы. Проанализированы данные 877 ..." | ||
| Vol 6, No 1S (2014): Special issue "Epilepsy" | Effectiveness of Epilepsy Therapy in Adults after Correction Performed by an Epileptologist | Abstract similar documents |
| S. R. Nurmukhametova, R. V. Magzhanov | ||
| "... on the results of examination and therapy correction performed by an epileptologist. Patients and Methods ..." | ||
| Vol 7, No 3 (2015) | Specific features of reperfusion therapy for vertebrobasilar ischemic stroke | Abstract similar documents |
| K. V. Anisimov, A. P. Tolmachev, Nikolai Anatolyevich Shamalov | ||
| "... and disability; reperfusion therapy in patients with a lesion focus in the VBS is safe and effective beyond the 4 ..." | ||
| Vol 6, No 3 (2014) | Factors influencing the efficiency and safety of systemic thrombolysis in patients with ischemic stroke | Abstract similar documents |
| N. A. Shamalov, K. V. Anisimov, M. A. Kustova, A. P. Tolmachev | ||
| "... and safe therapy option for ischemic stroke (IS) in the first 4.5 hours after onset of the disease ..." | ||
| Vol 6, No 3 (2014) | Analysis of reasons for low adherence to antiepileptic therapy in patients with symptomatic epilepsy | Abstract similar documents |
| M. A. Vagina, L. I. Volkova | ||
| "... of social stigmatization in epileptic patients. Patients with severe epilepsy on multiple drug therapy were ..." | ||
| Vol 4, No 1 (2012) | Fibromyalgia: development of symptoms and principles of therapy | Abstract similar documents |
| Gyuzel Rafkatovna Tabeyeva | ||
| Vol 5, No 4 (2013) | Platelet antiaggregants in the treatment and prevention of ischemic stroke | Abstract similar documents |
| Andrei Viktorovich Fonyakin | ||
| "... The review of literature gives current views on the role of antiplatelet therapy in the treatment ..." | ||
| Vol 5, No 3 (2013) | Analysis of factors influencing the early efficiency of systemic thrombolytic therapy for ischemic stroke | Abstract similar documents |
| Elena Vladimirovna Prazdnichkova, A M Alasheev, O A Shalagina, L I Volkova | ||
| "... he paper shows the urgency of enhancing the efficiency of systemic thrombolytic therapy (TLT ..." | ||
| Vol 14, No 3 (2022) | Combined therapy for Alzheimer's disease | Abstract similar documents |
| V. V. Zakharov, A. V. Lokshina, N. V. Vakhnina | ||
| "... to the problem of combined therapy of dementia in AD with donepezil and memantine are considered. The fixed ..." | ||
| Vol 11, No 3 (2019) | Advances in neurometabolic therapy | Abstract similar documents |
| V. V. Zakharov, N. V. Vakhnina | ||
| "... symmetric diabetic polyneuropathy and that it is used as additional therapy for primary degenerative ..." | ||
| Vol 9, No 3 (2017) | A chronobiological approach to therapy for depression | Abstract similar documents |
| M. Yu. Gerasimchuk | ||
| Vol 6, No 3 (2014) | Current therapy for Parkinson's disease | Abstract similar documents |
| A. V. Obukhova | ||
| "... The main goal of therapy for Parkinson's disease (PD) is to correct dopamine deficiency ..." | ||
| Vol 3, No 3 (2011) | Reperfusion therapy for ischemic stroke | similar documents |
| N. A. Shamalov, G. R. Ramazanov, K. V. Anisimov, V. I. Skvortsova | ||
| Vol 5, No 3 (2013) | Thrombolytic therapy for ischemic stroke | Abstract similar documents |
| Natalia Vyacheslavovna Pizova | ||
| "... .5 hours after onset of this disease. Thrombolytic therapy (TLT) promotes the achievement of reperfusion ..." | ||
| Vol 3, No 4 (2011) | Current therapy for cognitive impairments | Abstract similar documents |
| N. V. Vakhnina | ||
| "... , i.e. basic therapy for the most common forms of dementia (Alzheimer's disease, Lewy body dementia ..." | ||
| Vol 4, No 2 (2012) | Therapy for back pain syndrome | Abstract similar documents |
| E Yu Solovyeva | ||
| "... . To reduce the risk of adverse reactions of NSAID therapy, to enhance its adherence, and to reduce its cost ..." | ||
| Vol 13, No 1S (2021): Спецвыпуск: рассеянный склероз | Art therapy possibilities in the complex treatment of patients with multiple sclerosis | Abstract similar documents |
| M. E. Guseva, O. V. Matvievskaya, A. N. Boyko | ||
| "... Objective: to study the effectiveness of art therapy methods in the complex treatment ..." | ||
| Vol 10, No 3 (2018) | Effect of mexidol on the efficiency of intravenous thrombolytic therapy for ischemic stroke during the therapeutic window | Abstract similar documents |
| K. S. Knni, T. V. Dyomin, L. B. Adeeva | ||
| "... thrombolytic therapy (TLT) during the therapeutic window. Patients and methods. The retrospective study ..." | ||
| Vol 10, No 1 (2018) | New drugs for anti-B-cell therapy of multiple sclerosis | Abstract similar documents |
| A. N. Boyko, N. Yu. Lashch, M. E. Guseva | ||
| "... The review presents the data characterizing the mechanism of action of anti-B-cell therapy ..." | ||
| Vol 5, No 2S (2013): Special issue "Stroke" | Organization of prehospital medical care for patients with cerebral stroke | Abstract similar documents |
| Nikolai Anatolyevich Shamalov, A M Sidorov, A L Lukyanov | ||
| "... to verify the pattern of stroke are a guarantee of successful thrombolytic therapy that is the most ..." | ||
| Vol 15, No 1 (2023) | Predictive capabilities of the Cloninger Temperament and Character Inventory (TCI) in evaluating the effectiveness of antidepressant pharmacotherapy. Systematic review and meta-analysis | Abstract similar documents |
| A. V. Ovchinnikov, T. I. Vazagaeva, R. V. Akhapkin, B. A. Volel | ||
| "... found (Ntot=3122). The most commonly cited statistically significant predictors of therapy effectiveness ..." | ||
| Vol 9, No 2 (2017) | Antiplatelet therapy strategies for ischemic stroke | Abstract similar documents |
| M. Yu. Maksimova, A. V. Fonyakin, L. A. Geraskina | ||
| "... The paper considers the key areas of antithrombotic platelet therapy for ischemic stroke ..." | ||
| Vol 5, No 4 (2013) | Cognitive impairments in epilepsy | Abstract similar documents |
| Aleksandr Anatolyevich Kostylev, N V Pizova, N A Pizov | ||
| "... and duration of the disease, gender differences, and the impact of antiepileptic therapy. The role ..." | ||
| Vol 6, No 1S (2014): Special issue "Epilepsy" | A Clinical Analysis of Two Cases of Refractory Status Epilepticus of Generalized Convulsive Seizures | Abstract similar documents |
| V. A. Karlov, I. A. Zhidkova, P. N. Vlasov, B. P. Gladov, O. A. Podgornaya, S. V. Ukhanova | ||
| Vol 5, No 2S (2013): Special issue "Stroke" | Post-stroke cognitive impairments: diagnosis and therapeutic approaches | Abstract similar documents |
| Natalia Vyacheslavovna Pizova | ||
| "... and symptomatic therapy. Sermion is one of the promising agents for the prevention and treatment of CI ..." | ||
| Vol 4, No 1S (2012): Special issue "Epilepsy" | Possibilities to optimize pharmacotherapy for epilepsy according to the data of an epidemiological survey in Sterlitamak | Abstract similar documents |
| S. R. Nurmukhametova, R. V. Magzhanov | ||
| "... . Rational therapy can substantially enhance the control over epileptic seizures. ..." | ||
| Vol 4, No 1S (2012): Special issue "Epilepsy" | Hormone-dependent abnormality of the female sexual sphere during monotherapy with valproate, carbamazepine, and lamotrigine | Abstract similar documents |
| P. N. Vlasov, O. F. Serova, D. V. Dranko, N. V. Filatova, Z. S. Shakhabasova | ||
| Vol 3, No 4 (2011) | Neck pain: causes, diagnosis, treatment | Abstract similar documents |
| A. I. Isaikin | ||
| "... are indicated in cases of suspected serious pathology, ineffective standard medical therapy, elective manual ..." | ||
| Vol 1, No 1 (2009) | PSYCHOSOMATIC DISORDERS IN GASTROENTEROLOGICAL PRACTICE: FUNCTIONAL DYSPEPSIA | Abstract similar documents |
| L. V. Romasenko | ||
| "... , and gastroenterological studies in 103 patients treated at the gastroenterology clinic (Clinic of Faculty Therapy, I ..." | ||
| Vol 1, No 1 (2009) | Р-LIPOIC ACID PREPARATIONS IN THE TREATMENT OF DIABETIC NEUROPATHY | Abstract similar documents |
| O. E. Zinov'eva | ||
| "... evidence for the expedient use of r-lipoic acid preparations (Espa-lipon) in the therapy ..." | ||
| Vol 1, No 1 (2009) | USE OF ACTOVEGIN IN NEUROLOGY | Abstract similar documents |
| Yu. A. Starchina | ||
| "... to clinical neurological practice, including therapy for the diseases, the pathogenesis of which involves ..." | ||
| Vol 13, No 4 (2021) | Neuroprotective therapy in acute ischemic stroke | Abstract similar documents |
| A. A. Kulesh | ||
| "... The review discusses the role of neuroprotective therapy in the acute period of ischemic stroke ..." | ||
| Vol 13, No 5 (2021) | Adjunctive therapy for acute musculoskeletal pain | Abstract similar documents |
| V. A. Golovacheva, A. A. Golovacheva | ||
| "... ). Adjunctive therapy is usually used in combination with NSAIDs and is aimed to increase the effectiveness ..." | ||
| Vol 7, No 1 (2015) | Current therapy for chronic cerebrovascular attack | Abstract similar documents |
| A. A. Shmonin, V. S. Krasnov, I. A. Shmonina, E. V. Melnikova | ||
| "... requires a comprehensive approach. Effective combination therapy for CCVA involves secondary prevention ..." | ||
| Vol 11, No 1 (2019) | Antidepressant therapy in patients with cardiovascular diseases | Abstract similar documents |
| V. E. Medvedev, E. A. Korovyakova, V. I. Frolova, E. V. Gushanskaya | ||
| "... , and prognostic importance. Anti-antidepressant therapy promotes a more pronounced somatic stabilizing effect ..." | ||
| Vol 13, No 1 (2021) | Role of pathogenetic therapy for diabetic polyneuropathy | Abstract similar documents |
| D. A. Iskra, V. V. Kovalchuk, E. R. Barantsevich | ||
| "... In our country, alpha-lipoic acid is widely used as a pathogenetic therapy for diabetic ..." | ||
| Vol 11, No 3S (2019): Спецвыпуск: когнитивные нарушения, цереброваскулярные заболевания | Non-drug therapies for cognitive impairment | Abstract similar documents |
| I. S. Preobrazhenskaya, D. Fantalis, S. A. Abdyshova, A. A. Kindarova | ||
| "... -drug therapies in patients with Alzheimer’s disease. ..." | ||
| Vol 8, No 2 (2016) | Therapy for depression in bipolar affective disorder | Abstract similar documents |
| N. A. Tyuvina, I. G. Korobkova | ||
| "... Objective: to evaluate the efficiency and safety of different therapy regimens for depression ..." | ||
| Vol 9, No 1 (2017) | Drug therapy for peripheral vestibular vertigo | Abstract similar documents |
| L. M. Antonenko, V. A. Parfenov | ||
| "... for rehabilitation treatment, are used to treat vestibular vertigo. Drug therapy in combination with vestibular ..." | ||
| Vol 1, No 3-4 (2009) | COMPLEX THERAPY FOR HYPERTENSIVE AND MIXED ENCEPHALOPATHY | Abstract similar documents |
| S. A. Rumyantseva | ||
| Vol 3, No 3 (2011) | Poststroke cognitive impairments and their therapy with ceraxon | Abstract similar documents |
| N. V. Shakhparonova, A. S. Kadykov, E. M. Kashina | ||
| Vol 6, No 4 (2014) | Optimization of therapy in outpatients with chronic lumbago | Abstract similar documents |
| A. A. Averchenkova | ||
| "... and unassociated with a potentially dangerous spinal disease requiring emergency special therapy. Objective ..." | ||
| Vol 2, No 2 (2010) | Symptom modifiers in therapy for ankylosing spondylitis | Abstract similar documents |
| V. V. Badokin | ||
| Vol 4, No 4 (2012) | Combination therapy for pain in musculoskeletal diseases | Abstract similar documents |
| Andrei Evgenyevich Karateev | ||
| "... When managing patients with locomotor pathology, serious attention is paid to symptomatic therapy ..." | ||
| Vol 15 (2023): (Suppl. 1) | The evolution of interferon therapy in multiple sclerosis | Abstract similar documents |
| O. V. Boyko, N. F. Smirnova, A. N. Boyko | ||
| Vol 13, No 4 (2021) | Medication adherence in migraine patients (data of an online survey) | Abstract similar documents |
| N. A. Kovalchuk, E. A. Kiryanova, G. R. Tabeeva | ||
| "... Patient needs, drug intake patterns, and adherence to therapy are significant challenges ..." | ||
| Vol 14, No 4 (2022) | Adherence to antidepressant therapy: clinical experience on the example of agomelatine | Abstract similar documents |
| N. N. Petrova | ||
| "... , highlights the issues of adherence to antidepressant therapy, investigation of the safety and efficacy ..." | ||
| Vol 12, No 5 (2020) | Cervical dystonia: current rehabilitation strategies and methods | Abstract similar documents |
| A. S. Istomina, I. V. Miliukhina, M. D. Didur | ||
| "... and pathogenesis of the disease. As a supplement to botulinum toxin therapy, a multimodal physiotherapy program ..." | ||
| Vol 12, No 5 (2020) | The quality of prior antithrombotic therapy and the severity of ischemic stroke in atrial fibrillation | Abstract similar documents |
| L. A. Geraskina, M. M. Alieva, A. V. Fonyakin, M. Yu. Maksimova, N. I. Garabova, M. G. Burzhunova | ||
| "... antithrombotic therapy (ATT) on the clinical manifestations and outcomes of stroke remains a matter of debate ..." | ||
| Vol 13, No 2 (2021) | Malnutrition and perspectives of nutritional therapy for mental disorders | Abstract similar documents |
| D. V. Romanov, K. Yu. Dmitrenko | ||
| 1 - 70 of 754 Items | 1 2 3 4 5 6 7 8 9 10 > >> | |
Search tips:
- Search terms are case-insensitive
- Common words are ignored
- By default articles containing any term in the query are returned (i.e., OR is implied)
- Make sure that a word exists in an article by prefixing it with +; e.g., +journal +access scholarly academic
- Combine multiple words with AND to find articles containing all terms; e.g., education AND research
- Exclude a word by prefixing it with - or NOT; e.g., online -politics or online NOT politics
- Search for an exact phrase by putting it in quotes; e.g., "open access publishing". Hint: Quoting Chinese or Japanese words will help you to find exact word matches in mixed-language fields, e.g. "中国".
- Use parentheses to create more complex queries; e.g., archive ((journal AND conference) NOT theses)
